-
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis J. Gastroenterol. (IF 6.3) Pub Date : 2024-03-16 Daisuke Hirayama, Shinichiro Hyodo, Kazuo Morita, Hiroshi Nakase
-
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, randomized study J. Gastroenterol. (IF 6.3) Pub Date : 2024-03-16 Ho Suk Kang, Soo-Young Na, Jin Young Yoon, Yunho Jung, Geom Seog Seo, Jae Myung Cha
-
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia J. Gastroenterol. (IF 6.3) Pub Date : 2024-03-12 Hiroko Ikeda, Eikichi Ihara, Kosuke Takeya, Koji Mukai, Manabu Onimaru, Kenoki Ouchida, Yoshitaka Hata, Xiaopeng Bai, Yoshimasa Tanaka, Taisuke Sasaki, Fumiyo Saito, Masumi Eto, Jiro Nakayama, Yoshinao Oda, Masafumi Nakamura, Haruhiro Inoue, Yoshihiro Ogawa
-
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy J. Gastroenterol. (IF 6.3) Pub Date : 2024-03-11 Naohisa Yoshida, Ayako Maeda-Minami, Hideki Ishikawa, Michihiro Mutoh, Yuri Tomita, Reo Kobayashi, Hikaru Hashimoto, Ken Inoue, Ryohei Hirose, Osamu Dohi, Yoshito Itoh, Yasunari Mano
-
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma J. Gastroenterol. (IF 6.3) Pub Date : 2024-03-10 Hao-Yang Xin, Ji-Xue Zou, Rong-Qi Sun, Zhi-Qiang Hu, Zhuo Chen, Chu-Bin Luo, Zheng-Jun Zhou, Peng-Cheng Wang, Jia Li, Song-Yang Yu, Kai-Xuan Liu, Jia Fan, Jian Zhou, Shao-Lai Zhou
-
Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy J. Gastroenterol. (IF 6.3) Pub Date : 2024-02-29
Abstract Background Immune checkpoint inhibitor-related pancreatic injury (ICI-PI) is a rare occurrence, which has not been reported in detail. We conducted a retrospective multicenter study to determine the clinical characteristics, risk factors, and treatment of ICI-PI. Methods We reviewed the medical records of patients who received ICIs for malignant tumors between April 2014 and April 2019 at
-
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan J. Gastroenterol. (IF 6.3) Pub Date : 2024-02-27 Ken Yamashita, Shiro Oka, Takeshi Yamada, Keigo Mitsui, Hironori Yamamoto, Keiichi Takahashi, Akio Shiomi, Kinichi Hotta, Yoji Takeuchi, Toshio Kuwai, Fumio Ishida, Shin-Ei Kudo, Shoichi Saito, Masashi Ueno, Eiji Sunami, Tomoki Yamano, Michio Itabashi, Kazuo Ohtsuka, Yusuke Kinugasa, Takayuki Matsumoto, Tamotsu Sugai, Toshio Uraoka, Koichi Kurahara, Shigeki Yamaguchi, Tomohiro Kato, Masazumi Okajima
-
Indoleamine 2,3-dioxygenase 1-mediated iron metabolism in macrophages contributes to lipid deposition in nonalcoholic steatohepatitis J. Gastroenterol. (IF 6.3) Pub Date : 2024-02-24 Chaofeng Wu, Junjie Li, Hui Jia, Jiamin Zhao, Mengchen Qin, Hao Shi, Chang Liu, Jiajie Lin, Min Cai, Yong Gu, Bin Liu, Lei Gao
-
A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA J. Gastroenterol. (IF 6.3) Pub Date : 2024-02-05 Takehisa Watanabe, Sanae Hayashi, Yan Zhaoyu, Hiroki Inada, Katsuya Nagaoka, Masakuni Tateyama, Yasuhito Tanaka
-
CircDCBLD2 alleviates liver fibrosis by regulating ferroptosis via facilitating STUB1-mediated PARK7 ubiquitination degradation J. Gastroenterol. (IF 6.3) Pub Date : 2024-02-03
Abstract Background Liver fibrosis can progress to cirrhosis and hepatic carcinoma without treatment. CircDCBLD2 was found to be downregulated in liver fibrosis. However, the precise underlying mechanism requires further investigation. Methods qRT-PCR, Western blot, and immunohistochemistry assays were used to detect the related molecule levels. HE, Masson’s trichrome, and Sirius Red staining were
-
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-26 Makoto Naganuma, Naohiro Nakamura, Reiko Kunisaki, Katsuyoshi Matsuoka, Shojiro Yamamoto, Ami Kawamoto, Daisuke Saito, Taku Kobayashi, Kosaku Nanki, Kazuyuki Narimatsu, Hisashi Shiga, Motohiro Esaki, Shinichiro Yoshioka, Shingo Kato, Masayuki Saruta, Shinji Tanaka, Eriko Yasutomi, Kaoru Yokoyama, Kei Moriya, Yoshikazu Tsuzuki, Makoto Ooi, Mikihiro Fujiya, Atsushi Nakazawa, Tomohisa Takagi, Teppei Omori
-
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-25 Yuta Matsubara, Hiroki Kiyohara, Yohei Mikami, Kosaku Nanki, Ho Namkoong, Shotaro Chubachi, Hiromu Tanaka, Shuhei Azekawa, Shinya Sugimoto, Yusuke Yoshimatsu, Tomohisa Sujino, Kaoru Takabayashi, Naoki Hosoe, Toshiro Sato, Makoto Ishii, Naoki Hasegawa, Yukinori Okada, Ryuji Koike, Yuko Kitagawa, Akinori Kimura, Seiya Imoto, Satoru Miyano, Seishi Ogawa, Koichi Fukunaga, Takanori Kanai
-
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-24 Isabel Cornejo-Pareja, Mohamed Reda Amiar, Luís Ocaña-Wilhelmi, Rocío Soler-Humanes, Isabel Arranz-Salas, Lourdes Garrido-Sánchez, Carolina Gutiérrez-Repiso, Francisco Jose Tinahones
-
Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous polyposis in Japan: a nationwide multicenter study J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-23 Kazuhito Sasaki, Kazushige Kawai, Hiroaki Nozawa, Soichiro Ishihara, Hideyuki Ishida, Keiichiro Ishibashi, Yoshiko Mori, Satoki Shichijo, Yasuhiro Tani, Yoji Takeuchi, Akiko Chino, Misato Takao, Kenji Fujiyoshi, Takaaki Matsubara, Yasuyuki Miyakura, Fumitaka Taniguchi, Tatsuro Yamaguchi, Kohji Tanakaya, Naohiro Tomita, Yoichi Ajioka
-
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-23
Abstract Background We have previously reported apolipoprotein A2-isoforms (apoA2-is) as candidate plasma biomarkers for early-stage pancreatic cancer. The aim of this study was the clinical development of apoA2-is. Methods We established a new enzyme-linked immunosorbent sandwich assay for apoA2-is under the Japanese medical device Quality Management System requirements and performed in vitro diagnostic
-
Prevalence and risk factors for medication-refractory reflux esophagitis in patients with systemic sclerosis in Japan J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-22 Shiko Kuribayashi, Fumihiko Nakamura, Sei-Ichiro Motegi, Kenichiro Hara, Hiroko Hosaka, Akiko Sekiguchi, Mai Ishikawa, Yukie Endo, Tomonari Harada, Hidemi Sorimachi, Masaru Obokata, Mitsuo Uchida, Koichi Yamaguchi, Toshio Uraoka
Backgrounds Patients with systemic sclerosis (SSc) often have esophageal motility abnormalities and weak esophago-gastric junction (EGJ) barrier function, which causes proton pump inhibitor (PPI)-refractory reflux esophagitis (RE). The aims of this study were to clarify the current management of RE and prevalence and risk factors of medication-refractory RE in patients with SSc in Japan. Methods A
-
A combination of bowel wall thickness and submucosa index is useful for estimating endoscopic improvement in ulcerative colitis: external validation of the Kyorin Ultrasound Criterion J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-21
Abstract Background Endoscopic improvement (EI; a Mayo endoscopic subscore of 0 or 1) is considered a therapeutic target in ulcerative colitis (UC) treatment. The potential to estimate EI non-invasively is an advantage of intestinal ultrasound (IUS). In a previous study, we developed a new sonographic parameter, the submucosa index (SMI), calculated as the ratio of the submucosal thickness to bowel
-
Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-20
Abstract Background Recent evidence suggests that the presence of microbiome within human pancreatic ductal adenocarcinoma (PDAC) tissue potentially influences cancer progression and prognosis. However, the significance of tumor-resident microbiome remains unclear. We aimed to elucidate the impact of intratumoral bacteria on the pathophysiology and prognosis of human PDAC. Methods The presence of intratumoral
-
Gastric intestinal metaplasia: progress and remaining challenges J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-19
Abstract Most gastric cancers arise in the setting of chronic inflammation which alters gland organization, such that acid-pumping parietal cells are lost, and remaining cells undergo metaplastic change in differentiation patterns. From a basic science perspective, recent progress has been made in understanding how atrophy and initial pyloric metaplasia occur. However, pathologists and cancer biologists
-
Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease (GORD) pathogenesis J. Gastroenterol. (IF 6.3) Pub Date : 2024-01-14 Tom Leech, Madusha Peiris
-
Resistance exercise in combination with aerobic exercise reduces the incidence of serious events in patients with liver cirrhosis: a meta-analysis of randomized controlled trials J. Gastroenterol. (IF 6.3) Pub Date : 2023-12-30 Takumi Kawaguchi, Atsushi Kawaguchi, Ryuki Hashida, Dan Nakano, Tsubasa Tsutsumi, Machiko Kawaguchi, Shunji Koya, Keisuke Hirota, Manabu Tomita, Jin Tsuchihashi, Hayato Narao, Hiroo Matsuse, Koji Hiraoka, Keisuke Ejima, Shingo Iwami, Sachiyo Yoshio
-
Thiopurines exert harmful effects on spermatogenesis in Nudt15R138C knock-in mice J. Gastroenterol. (IF 6.3) Pub Date : 2023-12-15 Yoshihiro Yokota, Takayuki Imai, Masahiro Kawahara, Osamu Inatomi, Atsushi Nishida, Yoichi Kakuta, Atsushi Masamune, Akira Andoh
-
C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior. J. Gastroenterol. (IF 6.3) Pub Date : 2023-11-30 Masaru Enomoto,Naoshi Odagiri,Koji Rinka,Hirotsugu Maruyama,Yoshinori Shimamoto,Yuki Ishikawa-Kakiya,Yasuhiro Fujiwara,Norifumi Kawada,Masakazu Yashiro
-
Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database J. Gastroenterol. (IF 6.3) Pub Date : 2023-11-25 Tomoki Sakakida, Takeshi Ishikawa, Toshifumi Doi, Ryuichi Morita, Seita Kataoka, Hayato Miyake, Kanji Yamaguchi, Michihisa Moriguchi, Yoshio Sogame, Hiroaki Yasuda, Masahiro Iwasaku, Hideyuki Konishi, Koichi Takayama, Yoshito Itoh
-
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases J. Gastroenterol. (IF 6.3) Pub Date : 2023-11-25 Jun Omori, Mitsuru Kaise, Naoyoshi Nagata, Tomonori Aoki, Katsumasa Kobayashi, Atsushi Yamauchi, Atsuo Yamada, Takashi Ikeya, Taiki Aoyama, Naoyuki Tominaga, Yoshinori Sato, Takaaki Kishino, Naoki Ishii, Tsunaki Sawada, Masaki Murata, Akinari Takao, Kazuhiro Mizukami, Ken Kinjo, Shunji Fujimori, Takahiro Uotani, Minoru Fujita, Hiroki Sato, Sho Suzuki, Toshiaki Narasaka, Junnosuke Hayasaka, Tomohiro
-
The antiferroptotic effect of indigo on ulcerative colitis J. Gastroenterol. (IF 6.3) Pub Date : 2023-11-23 Shaopeng Sun, Bin Lv
The protective effect of indigo on intestinal epithelial cells remains unclear. Yokote Akihito et al. preliminarily investigated the anti-ferroptosis effect of indigo in inflammatory bowel disease. Here, we further discuss and evaluate the role of indigo based on the results.
-
Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathway J. Gastroenterol. (IF 6.3) Pub Date : 2023-11-22 Tomoyuki Kawaguchi, Koichi Okamoto, Shota Fujimoto, Masahiro Bando, Hironori Wada, Hiroshi Miyamoto, Yasushi Sato, Naoki Muguruma, Katsuhisa Horimoto, Tetsuji Takayama
-
Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation J. Gastroenterol. (IF 6.3) Pub Date : 2023-11-14 Chihiro Takeuchi, Junichi Sato, Nobutake Yamamichi, Natsuko Kageyama-Yahara, Akiko Sasaki, Takemi Akahane, Rika Aoki, Shigemi Nakajima, Masayoshi Ito, Mitsue Yamamichi, Yu-Yu Liu, Nobuyuki Sakuma, Yu Takahashi, Yoshiki Sakaguchi, Yosuke Tsuji, Kouhei Sakurai, Shuta Tomida, Keiko Niimi, Toshikazu Ushijima, Mitsuhiro Fujishiro
-
Editorial: Comparisons of COVID-19-related disturbance in diagnosis of esophagogastric cancer between the Netherlands and Japan. J. Gastroenterol. (IF 6.3) Pub Date : 2023-11-16 Katsunori Iijima,Kenta Watanabe,Yosuke Shimodaira
-
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers J. Gastroenterol. (IF 6.3) Pub Date : 2023-11-10 Yuki Kojima, Mamoru Tanaka, Makiko Sasaki, Keiji Ozeki, Takaya Shimura, Eiji Kubota, Hiromi Kataoka
-
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus J. Gastroenterol. (IF 6.3) Pub Date : 2023-11-05 Zhao Yang, Mengran Shi, Youfeng Liang, Fuhan Zhang, Cong Li, Yinying Lu, Taian Yin, Zhaohai Wang, Yongchao Li, Mingxuan Hao, Rui Guo, Hao Yang, Guanglin Lei, Fang Sun, Yu Zhang, Zhuoya Deng, Yuying Tian, Linxiang Yu, Changqing Bai, Lei Wang, Chuanxing Wan, Haifeng Wang, Penghui Yang
-
The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-30 Jia-Feng Wu, Steven Shinn-Forng Peng, Chi-San Tai, Wen-Hsi Lin, Yung-Ming Jeng, Wen-Ming Hsu, Huey-Ling Chen, Yen-Hsuan Ni, Mei-Hwei Chang
-
Clinicopathologic differences of gastric neoplasms between Helicobacter pylori-infected and -naïve patients: a multicenter retrospective analysis J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-19 Satoshi Kotani, Kotaro Shibagaki, Noriyuki Hirahara, Nobuaki Hasegawa, Ryo Tanabe, Yuri Ebisutani, Saya Nonomura, Kenichi Kishimoto, Yasuhide Kodama, Yusuke Takahashi, Masatoshi Kataoka, Akihiko Oka, Nobuhiko Fukuba, Yoshiyuki Mishima, Naoki Oshima, Kousaku Kawashima, Norihisa Ishimura, Asuka Araki, Kyuichi Kadota, Ayako Itawaki, Makoto Nagasaki, Yoichi Miyaoka, Hideyuki Onuma, Shunji Ishihara
-
Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-16 Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Nobuyoshi Kawamura, Yasushi Honda, Yuji Ogawa, Kento Imajo, Masato Yoneda, Satoru Saito, Atsushi Nakajima
-
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-16 Tatsunori Hanai, Kayoko Nishimura, Shinji Unome, Takao Miwa, Yuki Nakahata, Kenji Imai, Atsushi Suetsugu, Koji Takai, Masahito Shimizu
-
MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-16 Hanxiao Wang, You Li, Xiting Pu, Xueying Liang, Ruqi Tang, Xiong Ma
-
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-13 Yuki Tahata, Hayato Hikita, Satoshi Mochida, Nobuyuki Enomoto, Akio Ido, Hidekatsu Kuroda, Daiki Miki, Masayuki Kurosaki, Yoichi Hiasa, Ryotaro Sakamori, Norifumi Kawada, Taro Yamashita, Goki Suda, Hiroshi Yatsuhashi, Hitoshi Yoshiji, Naoya Kato, Taro Takami, Kazuhiko Nakao, Kentaro Matsuura, Yasuhiro Asahina, Yoshito Itoh, Ryosuke Tateishi, Yasunari Nakamoto, Eiji Kakazu, Shuji Terai, Masahito Shimizu
-
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-14 Fumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, Hitomi Sezaki, Norio Akuta, Shunichiro Fujiyama, Yusuke Kawamura, Satoshi Saitoh, Yasuji Arase, Mariko Kobayashi, Hiromitsu Kumada
-
Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-13 Makoto Naganuma, Taku Kobayashi, Reiko Kunisaki, Katsuyoshi Matsuoka, Shojiro Yamamoto, Ami Kawamoto, Daisuke Saito, Kosaku Nanki, Kazuyuki Narimatsu, Hisashi Shiga, Motohiro Esaki, Shinichiro Yoshioka, Shingo Kato, Masayuki Saruta, Shinji Tanaka, Eriko Yasutomi, Kaoru Yokoyama, Kei Moriya, Yoshikazu Tsuzuki, Makoto Ooi, Mikihiro Fujiya, Atsushi Nakazawa, Takayuki Abe, Tadakazu Hisamatsu
-
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-08 Haruki Uojima, Kadzuki Nakabayashi, Kazumi Yamasaki, Masaya Sugiyama, Norihiro Ishii, Ken Shirabe, Takuya Kyoutou, Koji Ueda, Yoichi Takahama, Nobuharu Tamaki, Masayuki Kurosaki, Hisashi Hidaka, Chika Kusano, Keisuke Amano, Takumi Kawaguchi, Akinobu Taketomi, Satoru Joshita, Takeji Umemura, Miyako Murakawa, Yasuhiro Asahina, Takanori Suzuki, Kentaro Matsuura, Takashi Nishimura, Hiroko Iijima, Kazumasa
-
Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study J. Gastroenterol. (IF 6.3) Pub Date : 2023-10-01 Ying-Ying Han, Lin Zhou, Yun-Lian Hu, Xiang-Wu Ding, Hui Long, Fei Liu, Ming Xu, Zhen-Yu Zhang, Shuang-Ling Li, Qiu-Yan Wang, Cheng-Xia Su, Yan Chen, Jie Chen, Ya Lin, Pei-Yuan Li
-
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenocarcinoma in Japan J. Gastroenterol. (IF 6.3) Pub Date : 2023-09-19 Kosuke Morimoto, Kensuke Moriwaki, Kojiro Shimozuma, Takeo Nakayama
-
Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern J. Gastroenterol. (IF 6.3) Pub Date : 2023-09-14 Akira Kado, Takeya Tsutsumi, Hiroshi Yotsuyanagi, Kazuhiko Ikeuchi, Kazuya Okushin, Kyoji Moriya, Kazuhiko Koike, Mitsuhiro Fujishiro
-
Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary–pancreatic cancers J. Gastroenterol. (IF 6.3) Pub Date : 2023-09-12 Yoshinori Ozono, Hiroshi Kawakami, Naomi Uchiyama, Hiroshi Hatada, Souichiro Ogawa
-
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort J. Gastroenterol. (IF 6.3) Pub Date : 2023-09-07 Takuji Okusaka, Akio Saiura, Kazuaki Shimada, Masafumi Ikeda, Tatsuya Ioka, Tetsuya Kimura, Jun Hosokawa, Atsushi Takita, Mari S. Oba
-
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis J. Gastroenterol. (IF 6.3) Pub Date : 2023-09-04 Chunlong Liu, Shijie Zhu, Jian Zhang, Panpan Wu, Xuan Wang, Sen Du, Enzhao Wang, Yunkang Kang, Kun Song, Jiangtao Yu
-
Analysis of the development of gastric cancer after resecting colorectal lesions using large-scale health insurance claims data J. Gastroenterol. (IF 6.3) Pub Date : 2023-08-30 Naohisa Yoshida, Ayako Maeda-Minami, Hideki Ishikawa, Michihiro Mutoh, Yui Kanno, Yuri Tomita, Ryohei Hirose, Osamu Dohi, Yoshito Itoh, Yasunari Mano
-
Application of polyglycolic acid sheets and basic fibroblast growth factor to prevent esophageal stricture after endoscopic submucosal dissection in pigs J. Gastroenterol. (IF 6.3) Pub Date : 2023-08-27 Yusuke Nishimura, Masayoshi Ono, Naoto Okubo, Takayuki Sone, Masayuki Higashino, Shogo Matsumoto, Marina Kubo, Keiko Yamamoto, Shoko Ono, Shunsuke Ohnishi, Naoya Sakamoto
-
The association between phosphate level at admission and early mortality in acute pancreatitis J. Gastroenterol. (IF 6.3) Pub Date : 2023-08-18 Maya Fischman, Adi Elias, Amir Klein, Yaron Cohen, Yael Levy, Zaher Shafiq Azzam, Itai Ghersin
-
Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI J. Gastroenterol. (IF 6.3) Pub Date : 2023-08-14 Yanli Zhang, Huiting Zhu, Shiyu Du, Huifen Wang, Hui Li, Miao Wang, Bing Shao
-
Brain activity in response to food images in patients with irritable bowel syndrome and functional dyspepsia J. Gastroenterol. (IF 6.3) Pub Date : 2023-08-12 Ryo Katsumata, Takayuki Hosokawa, Noriaki Manabe, Hitoshi Mori, Kenta Wani, Katsunori Ishii, Tomohiro Tanikawa, Noriyo Urata, Maki Ayaki, Ken Nishino, Takahisa Murao, Mitsuhiko Suehiro, Minoru Fujita, Miwa Kawanaka, Ken Haruma, Hirofumi Kawamoto, Toshihiro Takao, Tomoari Kamada
-
Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT J. Gastroenterol. (IF 6.3) Pub Date : 2023-08-10 Kenji Watanabe, Masanori Nojima, Hiroshi Nakase, Toshiyuki Sato, Minoru Matsuura, Nobuo Aoyama, Taku Kobayashi, Hirotake Sakuraba, Masakazu Nishishita, Kaoru Yokoyama, Motohiro Esaki, Fumihito Hirai, Masakazu Nagahori, Sohachi Nanjo, Teppei Omori, Satoshi Tanida, Yoshihiro Yokoyama, Kei Moriya, Atsuo Maemoto, Osamu Handa, Naoki Ohmiya, Kiichiro Tsuchiya, Shinichiro Shinzaki, Shingo Kato, Toshio Uraoka
-
Comparison of a novel mini-oral sulfate tablet and the conventional oral sulfate tablet in bowel preparation for colonoscopy: a prospective, randomized, investigator-blinded, multicenter, non-inferior, phase 3 trial J. Gastroenterol. (IF 6.3) Pub Date : 2023-08-05 Seong Ran Jeon, Soo-Kyung Park, Dong-Hoon Yang, Jae Myung Cha
-
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices J. Gastroenterol. (IF 6.3) Pub Date : 2023-08-01 Fujimasa Tada, Atsushi Hiraoka, Toshifumi Tada, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Naganuma, Hisashi Kosaka, Tomomitsu Matono, Hidekatsu
-
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer J. Gastroenterol. (IF 6.3) Pub Date : 2023-07-31 Benthe H. Doeve, Jeanne A. C. Bakx, Peter D. Siersema, Camiel Rosman, Nicole C. T. van Grieken, Mark I. van Berge Henegouwen, Johanna W. van Sandick, Marcel Verheij, Maarten F. Bijlsma, Rob H. A. Verhoeven, Hanneke W. M. van Laarhoven
-
Exploring the challenge of early gastric cancer diagnostic AI system face in multiple centers and its potential solutions J. Gastroenterol. (IF 6.3) Pub Date : 2023-07-29 Zehua Dong, Xiao Tao, Hongliu Du, Junxiao Wang, Li Huang, Chiyi He, Zhifeng Zhao, Xinli Mao, Yaowei Ai, Beiping Zhang, Mei Liu, Hong Xu, Zhenyu Jiang, Yunwei Sun, Xiuling Li, Zhihong Liu, Jinzhong Chen, Ying Song, Guowei Liu, Chaijie Luo, Yanxia Li, Xiaoquan Zeng, Jun Liu, Yijie Zhu, Lianlian Wu, Honggang Yu
-
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases J. Gastroenterol. (IF 6.3) Pub Date : 2023-07-29 Hiroki Oyama, Tsuyoshi Hamada, Yousuke Nakai, Mariko Tanaka, Go Endo, Ryunosuke Hakuta, Kota Ishida, Kazunaga Ishigaki, Sachiko Kanai, Kohei Kurihara, Tomotaka Saito, Tatsuya Sato, Tatsunori Suzuki, Yukari Suzuki, Shinya Takaoka, Shuichi Tange, Yurie Tokito, Naminatsu Takahara, Tetsuo Ushiku, Mitsuhiro Fujishiro
-
Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma J. Gastroenterol. (IF 6.3) Pub Date : 2023-07-27 Chenglin Xie, Xu Ye, Li Zeng, Xi Zeng, Deliang Cao
-
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis J. Gastroenterol. (IF 6.3) Pub Date : 2023-07-25 Gareth Parkes, Ryan C. Ungaro, Silvio Danese, Maria T. Abreu, Ethan Arenson, Wen Zhou, Dapo Ilo, F. Stephen Laroux, Huiwen Deng, Yuri Sanchez Gonzalez, Laurent Peyrin-Biroulet
-
Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter randomized controlled trial J. Gastroenterol. (IF 6.3) Pub Date : 2023-07-24 Min Wei, Yong Chen, Minghui Wang, Jinhou Li, Yunqing Zeng, Xin Sun, Anzhong Zhang, Xiaofeng Liu, Tao Zhou, Yanjing Gao